Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Huang, Y.; Higuchi, Y.; Kinoshita, T.; Mitani, A.; Eshima, Y.; Takegawa, K.
    Characterization of novel endo-?-N-acetylglucosaminidases from Sphingobacterium species, Beauveria bassiana and Cordyceps militaris that specifically hydrolyze fucose-containing oligosaccharides and human IgG (2018), Sci. Rep., 8, 246 .
    View publication on PubMedView publication on EuropePMC

Cloned(Commentary)

EC Number Cloned (Comment) Organism
3.2.1.96 expression in Escherichia coli BL21-CodonPlus (DE3) Sphingobacterium sp.
3.2.1.96 expression in Escherichia coli BL21-CodonPlus (DE3) Beauveria bassiana
3.2.1.96 expression in Escherichia coli BL21-CodonPlus (DE3) Cordyceps militaris

Organism

EC Number Organism UniProt Comment Textmining
3.2.1.96 Beauveria bassiana J4WAU5
-
-
3.2.1.96 Beauveria bassiana ARSEF 2860 J4WAU5
-
-
3.2.1.96 Cordyceps militaris G3JPF7
-
-
3.2.1.96 Cordyceps militaris CM01 G3JPF7
-
-
3.2.1.96 Sphingobacterium sp. A0A2Z5VGL1
-
-
3.2.1.96 Sphingobacterium sp. A0A2Z5VGM9
-
-
3.2.1.96 Sphingobacterium sp. A0A2Z5VGN0
-
-
3.2.1.96 Sphingobacterium sp. A0A2Z5VGV8
-
-

Purification (Commentary)

EC Number Purification (Comment) Organism
3.2.1.96
-
Sphingobacterium sp.
3.2.1.96
-
Beauveria bassiana
3.2.1.96
-
Cordyceps militaris

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.2.1.96 additional information the enzyme can hydrolytically remove fucose-containing oligosaccharides from glycoproteins. The enzyme specicically hydrolyzes fucose-containing biantennary oligosaccharides. It exhibits higher activity for the substrate containing terminal sialic acid with the alpha2,3-linkage. Terminal fucosylation is not accepted Sphingobacterium sp. ?
-
?
3.2.1.96 additional information the enzyme can hydrolytically remove fucose-containing oligosaccharides from glycoproteins. The enzyme specicically hydrolyzes fucose-containing biantennary oligosaccharides. It exhibits higher activity for the substrate containing terminal sialic acid with the alpha2,3-linkage. Terminal fucosylation is not accepted Cordyceps militaris ?
-
?
3.2.1.96 additional information the enzyme can hydrolytically remove fucose-containing oligosaccharides from glycoproteins. The enzyme specicically hydrolyzes fucose-containing biantennary oligosaccharides. It exhibits higher activity for the substrate containing terminal sialic acid with the alpha2,3-linkage. Terminal fucosylation is not accepted as a substrate Beauveria bassiana ?
-
?
3.2.1.96 additional information the enzyme can hydrolytically remove fucose-containing oligosaccharides from glycoproteins. The enzyme specifically hydrolyzes fucose-containing biantennary oligosaccharides. It exhibits higher activity for the substrate containing terminal sialic acid with the alpha2,3-linkage. Terminal fucosylation is not accepted Sphingobacterium sp. ?
-
?
3.2.1.96 additional information the enzyme can hydrolytically remove fucose-containing oligosaccharides from glycoproteins. The enzyme specicically hydrolyzes fucose-containing biantennary oligosaccharides. It exhibits higher activity for the substrate containing terminal sialic acid with the alpha2,3-linkage. Terminal fucosylation is not accepted as a substrate Beauveria bassiana ARSEF 2860 ?
-
?
3.2.1.96 additional information the enzyme can hydrolytically remove fucose-containing oligosaccharides from glycoproteins. The enzyme specicically hydrolyzes fucose-containing biantennary oligosaccharides. It exhibits higher activity for the substrate containing terminal sialic acid with the alpha2,3-linkage. Terminal fucosylation is not accepted Cordyceps militaris CM01 ?
-
?
3.2.1.96 rituximab + H2O releases the fucose-containing oligosaccharides residues from rituximab (immunoglobulin G) but not the high-mannose-containing oligosaccharides residues from RNase B Sphingobacterium sp. ?
-
?
3.2.1.96 rituximab + H2O releases the fucose-containing oligosaccharides residues from rituximab (immunoglobulin G) but not the high-mannose-containing oligosaccharides residues from RNase B Beauveria bassiana ?
-
?
3.2.1.96 rituximab + H2O releases the fucose-containing oligosaccharides residues from rituximab (immunoglobulin G) but not the high-mannose-containing oligosaccharides residues from RNase B Cordyceps militaris ?
-
?
3.2.1.96 rituximab + H2O releases the fucose-containing oligosaccharides residues from rituximab (immunoglobulin G) but not the high-mannose-containing oligosaccharides residues from RNase B Beauveria bassiana ARSEF 2860 ?
-
?
3.2.1.96 rituximab + H2O releases the fucose-containing oligosaccharides residues from rituximab (immunoglobulin G) but not the high-mannose-containing oligosaccharides residues from RNase B Cordyceps militaris CM01 ?
-
?

Synonyms

EC Number Synonyms Comment Organism
3.2.1.96 endo-beta-N-acetylglucosaminidase
-
Sphingobacterium sp.
3.2.1.96 endo-beta-N-acetylglucosaminidase
-
Beauveria bassiana
3.2.1.96 endo-beta-N-acetylglucosaminidase
-
Cordyceps militaris
3.2.1.96 ENGase
-
Sphingobacterium sp.
3.2.1.96 ENGase
-
Beauveria bassiana
3.2.1.96 ENGase
-
Cordyceps militaris

pH Optimum

EC Number pH Optimum Minimum pH Optimum Maximum Comment Organism
3.2.1.96 2.3
-
-
Sphingobacterium sp.
3.2.1.96 2.5
-
-
Sphingobacterium sp.